164 related articles for article (PubMed ID: 36314436)
1. Efficacy of ganciclovir versus foscarnet in ganciclovir-resistant cytomegalovirus retinitis: A case report.
Lee HJ; Woo SJ
Eur J Ophthalmol; 2023 Sep; 33(5):NP105-NP108. PubMed ID: 36314436
[TBL] [Abstract][Full Text] [Related]
2. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
Desatnik HR; Foster RE; Lowder CY
Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
[TBL] [Abstract][Full Text] [Related]
3. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
4. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
5. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
6. Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches.
Fu L; Santhanakrishnan K; Al-Aloul M; Jones NP; Steeples LR
Ocul Immunol Inflamm; 2020 Oct; 28(7):1152-1158. PubMed ID: 31621449
[No Abstract] [Full Text] [Related]
7. Intravitreal foscarnet for recurring CMV retinitis in a congenitally infected premature infant.
Tawse KL; Baumal CR
J AAPOS; 2014 Feb; 18(1):78-80. PubMed ID: 24568990
[TBL] [Abstract][Full Text] [Related]
8. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
9. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
10. Dual Intravitreal Injections With Foscarnet and Ganciclovir for Ganciclovir-Resistant Recurrent Cytomegalovirus Retinitis in a Congenitally Infected Infant.
Boss JD; Rosenberg K; Shah R
J Pediatr Ophthalmol Strabismus; 2016 Oct; 53():e58-e60. PubMed ID: 27783090
[TBL] [Abstract][Full Text] [Related]
11. Design of clinical trials for drug combinations: cytomegalovirus retinitis--foscarnet and ganciclovir. The CMV retinitis retreatment trial.
Jabs DA
Antiviral Res; 1996 Jan; 29(1):69-71. PubMed ID: 8721550
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic developments in cytomegalovirus retinitis.
Hoffman VF; Skiest DJ
Expert Opin Investig Drugs; 2000 Feb; 9(2):207-20. PubMed ID: 11060672
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
Ries E; Mühlbauer B; Ruhswurm I; Krepler K; Derbolav A; Svolba G; Rieger A; Wedrich A
Ophthalmologica; 1998; 212(4):239-43. PubMed ID: 9672212
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic options for resistant cytomegalovirus retinitis.
Kuppermann BD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S13-21. PubMed ID: 9058613
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of ganciclovir in the human retina.
Park SS; Girard B; Font RL; Hauw JJ; Young LH
Curr Eye Res; 1998 Jun; 17(6):663-7. PubMed ID: 9663857
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient.
Okamoto T; Okada M; Mori A; Saheki K; Takatsuka H; Wada H; Tamura A; Fujimori Y; Takemoto Y; Kanamaru A; Kakishita E
Bone Marrow Transplant; 1997 Nov; 20(9):801-3. PubMed ID: 9384487
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant.
Ufret-Vincenty RL; Singh RP; Lowder CY; Kaiser PK
Am J Ophthalmol; 2007 Feb; 143(2):334-5. PubMed ID: 17258523
[TBL] [Abstract][Full Text] [Related]
18. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
Wutoh AK; Hidalgo J; Rhee W; Bareta J; Steidl S
Am J Health Syst Pharm; 1999 Jul; 56(13):1314-8. PubMed ID: 10683128
[TBL] [Abstract][Full Text] [Related]
19. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of CMV retinitis with intravitreal foscarnet].
Cochereau I; Belayachi N; Diraison C; Matheron S; Bouyer I; Hoang-Xuan T; Saimot AG; Coulaud JP
J Fr Ophtalmol; 1998 Dec; 21(10):723-6. PubMed ID: 10052044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
